Indication
Schizophrenia
The Schizophrenia pipeline: 68 tracked drugs, 36 approved for this indication.
36 approved / phase 410 Phase 313 Phase 22 Phase 1/26 Phase 11 preclinical / unstaged
Compare the share prices of listed companies in Schizophrenia →
Total attributable cost
$36.7B
$11,952/patient
Drug spend
$15.6B
$5,069/patient
42% of total cost is drugs
All severities · US